Literature DB >> 21508130

Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes.

Lindsey George1, Fida Bacha, Sojung Lee, Hala Tfayli, Elisa Andreatta, Silva Arslanian.   

Abstract

CONTEXT: In epidemiological studies of childhood obesity, simple and reliable surrogate estimates of insulin sensitivity are needed because the gold standard, the hyperinsulinemic-euglycemic clamp, is not feasible on a large scale.
OBJECTIVE: To examine the correlation of fasting and oral glucose tolerance test (OGTT)-derived surrogate indices of insulin sensitivity with the hyperinsulinemic-euglycemic clamp in obese adolescents with normal glucose tolerance, prediabetes, and diabetes. PATIENTS AND
DESIGN: A total of 188 overweight/obese adolescents (10 to <20 yr old) who completed a standard 2-h OGTT and 3-h hyperinsulinemic-euglycemic clamp were included. Fasting-derived surrogates [fasting glucose (G(F)), fasting insulin (I(F)), 1/I(F), G(F)/I(F), homeostasis model assessment and quantitative insulin sensitivity check index] and OGTT-derived surrogates [whole-body insulin sensitivity index and the ratio of glucose and insulin areas under the curve (Gluc(AUC)/Ins(AUC))] were calculated. MAIN OUTCOME MEASURES: We evaluated the correlations between the clamp-measured insulin sensitivity and the surrogate estimates and area under the receiver operating characteristic curves.
RESULTS: Fasting indices (1/I(F), G(F)/I(F), homeostasis model assessment of insulin sensitivity, and quantitative insulin sensitivity check index) correlated significantly with clamp insulin sensitivity (r = 0.82, 0.78, 0.81, and 0.80, respectively), with lower correlations between the OGTT surrogates and clamp (whole-body insulin sensitivity index, r = 0.77; Gluc(AUC)/Ins(AUC), r = 0.62). The area under the receiver operating characteristic curves was more than or equal to 0.94 for all surrogates except Gluc(AUC)/Ins(AUC.) Across quartiles of clamp-measured insulin sensitivity, there was a significant overlap in individual values of I(F), 1/I(F), and G(F)/I(F).
CONCLUSION: In obese adolescents with normal or impaired glucose tolerance or diabetes, OGTT-derived surrogates do not offer any advantage over the simpler fasting indices, which correlate strongly with clamp insulin sensitivity. Surrogate indices of insulin sensitivity could be used in epidemiological studies but not to define insulin resistance in individual patients or research subjects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21508130      PMCID: PMC3205514          DOI: 10.1210/jc.2010-2813

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  37 in total

Review 1.  Use and abuse of HOMA modeling.

Authors:  Tara M Wallace; Jonathan C Levy; David R Matthews
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

Review 2.  The global spread of type 2 diabetes mellitus in children and adolescents.

Authors:  Orit Pinhas-Hamiel; Philip Zeitler
Journal:  J Pediatr       Date:  2005-05       Impact factor: 4.406

3.  Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children.

Authors:  Gabriel I Uwaifo; Erica M Fallon; Jeff Chin; Jane Elberg; Shamik J Parikh; Jack A Yanovski
Journal:  Diabetes Care       Date:  2002-11       Impact factor: 19.112

4.  Six-month exenatide improves HOMA hyperbolic product in type 2 diabetic patients mostly by enhancing beta-cell function rather than insulin sensitivity.

Authors:  V Preumont; M-P Hermans; S Brichard; M Buysschaert
Journal:  Diabetes Metab       Date:  2010-05-05       Impact factor: 6.041

5.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

6.  Insulin resistance: link to the components of the metabolic syndrome and biomarkers of endothelial dysfunction in youth.

Authors:  SoJung Lee; Neslihan Gungor; Fida Bacha; Silva Arslanian
Journal:  Diabetes Care       Date:  2007-05-02       Impact factor: 19.112

7.  Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007).

Authors:  Alireza Esteghamati; Haleh Ashraf; Omid Khalilzadeh; Ali Zandieh; Manouchehr Nakhjavani; Armin Rashidi; Mehrdad Haghazali; Fereshteh Asgari
Journal:  Nutr Metab (Lond)       Date:  2010-04-07       Impact factor: 4.169

8.  Comparison between beta-cell function and insulin resistance indexes in prepubertal and pubertal obese children.

Authors:  Gabriele Guzzaloni; Graziano Grugni; Giuliana Mazzilli; Dario Moro; Francesco Morabito
Journal:  Metabolism       Date:  2002-08       Impact factor: 8.694

9.  Indexes of insulin resistance and secretion in obese children and adolescents: a validation study.

Authors:  Louise S Conwell; Stewart G Trost; Wendy J Brown; Jennifer A Batch
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

10.  Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients.

Authors:  Hala Tfayli; Fida Bacha; Neslihan Gungor; Silva Arslanian
Journal:  Diabetes       Date:  2008-12-10       Impact factor: 9.461

View more
  56 in total

Review 1.  Insulin resistance in type 2 diabetic youth.

Authors:  Kara Mizokami-Stout; Melanie Cree-Green; Kristen J Nadeau
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-08       Impact factor: 3.243

2.  Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.

Authors:  Petter Bjornstad; Lori Laffel; Jane Lynch; Laure El Ghormli; Ruth S Weinstock; Sherida E Tollefsen; Kristen J Nadeau
Journal:  Diabetes Care       Date:  2019-04-09       Impact factor: 19.112

3.  Correlates of Medication Adherence in the TODAY Cohort of Youth With Type 2 Diabetes.

Authors:  Lorraine Levitt Katz; Barbara J Anderson; Siripoom V McKay; Roberto Izquierdo; Terri L Casey; Laurie A Higgins; Aimee Wauters; Kathryn Hirst; Kristen J Nadeau
Journal:  Diabetes Care       Date:  2016-06-28       Impact factor: 19.112

Review 4.  Estimation of insulin sensitivity in children: methods, measures and controversies.

Authors:  Rebecca J Brown; Jack A Yanovski
Journal:  Pediatr Diabetes       Date:  2014-04-23       Impact factor: 4.866

5.  Beta cell function and insulin sensitivity in obese youth with maturity onset diabetes of youth mutations vs type 2 diabetes in TODAY: Longitudinal observations and glycemic failure.

Authors:  Silva Arslanian; Laure El Ghormli; Morey H Haymond; Christine L Chan; Steven D Chernausek; Rachelle G Gandica; Rose Gubitosi-Klug; Lynne L Levitsky; Maggie Siska; Steven M Willi
Journal:  Pediatr Diabetes       Date:  2020-03-03       Impact factor: 4.866

6.  Early testing of insulin resistance: a tale of two lipid ratios in a group of 5th graders screened by the Coronary Artery Risk Detection in Appalachian Communities Project (CARDIAC Project).

Authors:  Charles Ituka Mosimah; Christa Lilly; Awung-Njia Forbin; Pamela J Murray; Lee Pyles; Elloise Elliot; William Neal
Journal:  World J Pediatr       Date:  2019-05-04       Impact factor: 2.764

Review 7.  Methods for Measuring Risk for Type 2 Diabetes in Youth: the Oral Glucose Tolerance Test (OGTT).

Authors:  Melinda E Chen; Rebecca S Aguirre; Tamara S Hannon
Journal:  Curr Diab Rep       Date:  2018-06-16       Impact factor: 4.810

8.  Adipose Tissue Insulin Resistance in Youth on the Spectrum From Normal Weight to Obese and From Normal Glucose Tolerance to Impaired Glucose Tolerance to Type 2 Diabetes.

Authors:  Joon Young Kim; Fida Bacha; Hala Tfayli; Sara F Michaliszyn; Shahwar Yousuf; Silva Arslanian
Journal:  Diabetes Care       Date:  2018-11-19       Impact factor: 19.112

9.  The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test: Forerunner of Heightened Glycemic Failure Rates and Accelerated Decline in β-Cell Function in TODAY.

Authors:  Silva Arslanian; Laure El Ghormli; Joon Young Kim; Fida Bacha; Christine Chan; Heba M Ismail; Lorraine E Levitt Katz; Lynne Levitsky; Jeanie B Tryggestad; Neil H White
Journal:  Diabetes Care       Date:  2018-11-19       Impact factor: 19.112

10.  Relationship Between Parental Diabetes and Presentation of Metabolic and Glycemic Function in Youth With Type 2 Diabetes: Baseline Findings From the TODAY Trial.

Authors:  Steven D Chernausek; Silva Arslanian; Sonia Caprio; Kenneth C Copeland; Laure El ghormli; Megan M Kelsey; Michaela B Koontz; Carisse M Orsi; Denise Wilfley
Journal:  Diabetes Care       Date:  2015-11-17       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.